Mouse model sheds light on vision loss in rare human disease

Researchers have mapped how and when sight deteriorates in a rare disorder, opening the door to the development and testing of gene therapies as treatments.

Head shot of Roly Megaw in the lab

Mucopolysaccharidosis type IIIC (MPSIIIC) is caused by mutations in the HGSNAT gene, leading to sight loss and retinal degeneration.

In a bid to understand what causes the disease, researchers at the universities of Edinburgh and Manchester mapped what happens in the retinas of mice which carry this mutation.

The team, led by Professor Brian Bigger and Dr Shaun Wood at the Institute of Regeneration and Repair and including Dr Roly Megaw and Lisa McKie at IGC, used a combination of advanced techniques to monitor the retina - the light-sensitive photoreceptor cells at the back of the eye - as the mice aged.

They found the animals undergo early-onset retinal degeneration, with subsequent loss of vision. 

These findings closely mirror what happens in patients carrying mutations in this gene. It therefore suggests that the mouse model could prove highly valuable for developing and testing gene therapies as treatments to prevent the sight loss suffered by patients with this devastating disease. 

Related links